Home 禄 Metro 禄 Health and Science
Local scientists help with TB discovery
By Cai Wenjun |
July 3, 2012, Tuesday
|
Print Edition
Print Edition
LOCAL scientists have helped discover a new compound to inhibit and kill the tuberculosis bacterium, a deadly pathogen which has a rising resistance to current medication.
The announcement was made yesterday by officials from the National Center for Drug Screening and the Chinese National Compound Library located in Shanghai.
The discovery, made with scientists from four other nations, will lead to development of new drugs, officials said.
Tuberculosis claims about 1.4 million lives in the world every year, and 95 percent of cases and deaths take place in developing countries. It also is one of the three major infectious disease in China apart from AIDS and viral hepatitis.
"This compound is the first discovery under the collaboration between the library and the World Health Organization," said Wang Mingwei, director, screening center and library.
"All diseases in the program are ... diseases and health conditions more prevalent among the poor than among the rich, and giant pharmaceutical companies don't conduct research and drug development for low profits," Wang said.
With the world's largest public collection of compounds, China undertook the collaboration with WHO to step up research on diseases more common in China and other developing countries.
The announcement was made yesterday by officials from the National Center for Drug Screening and the Chinese National Compound Library located in Shanghai.
The discovery, made with scientists from four other nations, will lead to development of new drugs, officials said.
Tuberculosis claims about 1.4 million lives in the world every year, and 95 percent of cases and deaths take place in developing countries. It also is one of the three major infectious disease in China apart from AIDS and viral hepatitis.
"This compound is the first discovery under the collaboration between the library and the World Health Organization," said Wang Mingwei, director, screening center and library.
"All diseases in the program are ... diseases and health conditions more prevalent among the poor than among the rich, and giant pharmaceutical companies don't conduct research and drug development for low profits," Wang said.
With the world's largest public collection of compounds, China undertook the collaboration with WHO to step up research on diseases more common in China and other developing countries.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
